Abstract
The Su-PS and Su-PR skin reaction was determined in 144 patients with gastric cancer, and the following results were obtained.
1) The Su-PS and Su-PR skin reaction was found to be a possible parameter for determination of immunological competence accompanying the advance of gastric cancer.
2) The Su-PS skin reaction was a parameter representing the sensitivity of gastric cancer patients to OK-432.
3) Changes in the Su-PS skin reaction provided an index for evaluating the therapeutic effects of OK-432 administration in patients with gastric cancer.
These results suggest that the Su-PS and Su-PR skin reaction tests are important in the treatment of patients with gastric cancer.
